Lazard Asset Management
LMAT icon

Lazard Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Lazard Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
61,333
+11,026
+22% +$1.13M 0.01% 572
2026
Q1 		$5.49M Buy
50,307
+4,901
+11% +$467K 0.01% 538
2025
Q4 		$3.68M Buy
45,406
+1,546
+4% +$133K 0.01% 651
2025
Q3 		$3.84M Sell
43,860
-1,902
-4% -$170K 0.01% 648
2025
Q2 		$3.8M Buy
45,762
+5,849
+15% +$489K 0.01% 815
2025
Q1 		$3.35M Buy
39,913
+37,795
+1,784% +$3.52M 0.01% 809
2024
Q4 		$194K Sell
2,118
-100
-5% -$9.62K ﹤0.01% 1619
2024
Q3 		$204K Sell
2,218
-3
-0.1% -$260 ﹤0.01% 1607
2024
Q2 		$182K Buy
2,221
+568
+34% +$41.7K ﹤0.01% 1589
2024
Q1 		$108K Sell
1,653
-78
-5% -$4.81K ﹤0.01% 1510
2023
Q4 		$98K Sell
1,731
-8,719
-83% -$457K ﹤0.01% 1661
2023
Q3 		$568K Buy
10,450
+1,822
+21% +$108K ﹤0.01% 1115
2023
Q2 		$579K Buy
+8,628
New +$526K ﹤0.01% 1088
2022
Q4 		– Sell
-1,026
Closed -$51K – 2492
2022
Q3 		$51K Sell
1,026
-1,537
-60% -$76.8K ﹤0.01% 1796
2022
Q2 		$116K Buy
2,563
+841
+49% +$37.6K ﹤0.01% 1462
2022
Q1 		$80K Hold
1,722
– – ﹤0.01% 1503
2021
Q4 		$86K Buy
1,722
+169
+11% +$8.74K ﹤0.01% 1498
2021
Q3 		$82K Sell
1,553
-88
-5% -$4.96K ﹤0.01% 1475
2021
Q2 		$100K Hold
1,641
– – ﹤0.01% 1342
2021
Q1 		$80K Buy
1,641
+459
+39% +$21.5K ﹤0.01% 1259
2020
Q4 		$47K Buy
+1,182
New +$42.2K ﹤0.01% 1411
2020
Q3 		– Sell
-1,884
Closed -$49K – 1679
2020
Q2 		$49K Buy
+1,884
New +$49.3K ﹤0.01% 1231

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Lazard Asset Management's LMAT Position: Q2 2026 in Review

Lazard Asset Management increased its LeMaitre Vascular (LMAT) stake by 22% in Q2 2026, buying an estimated $1.13M and bringing the position to 61,333 shares worth $5.89M. The position accounts for 0.01% of the portfolio, ranked #572.

Lazard Asset Management first reported a position in LMAT in Q2 2020 and has held it in 22 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Lazard Asset Management held 61,333 shares of LeMaitre Vascular worth $5.89M as of Q2 2026.
  • Lazard Asset Management bought 11,026 LeMaitre Vascular shares in Q2 2026, an estimated $1.13M.
  • LeMaitre Vascular made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #572 holding.
  • Lazard Asset Management first reported a position in LeMaitre Vascular in Q2 2020 and has held it in 22 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.